NCT05308160 A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease Status UNKNOWN Phase PHASE3
NCT05280145 Efficacy of the echOpen Device to Detect Pyelocaliceal Dilation and Hepatic Steatosis Status COMPLETED Phase NA
NCT05015491 Effects of Online App Weight Loss Programs on Liver Health in Obese Adults Status COMPLETED Phase NA
NCT04971434 Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping Status UNKNOWN Phase NA
NCT04873258 Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease Status RECRUITING Phase N/A
NCT04853082 Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution Status COMPLETED Phase EARLY_PHASE1
NCT04702490 Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH Status UNKNOWN Phase PHASE2
NCT04463667 Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease Status UNKNOWN Phase NA
NCT04371042 PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies Status RECRUITING Phase N/A
NCT04281121 Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver Status COMPLETED Phase NA